Pay-for-delay ruling exposes uncertainty in EU law
The Paroxetine judgment in the UK highlights a slew of questions that the EU courts have yet to resolve about patent settlements, and takes issue with the UK competition enforcer’s reasoning on market definitions. Tom Webb scrutinises the ruling
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10